

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.42228652 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.13446858 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.13446858 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.92499329 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.73499243 |
| 6 | positive regulation of B cell differentiation (GO:0045579) | 4.58873994 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.32309513 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 4.24419707 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.03953477 |
| 10 | regulation of mast cell degranulation (GO:0043304) | 4.00251801 |
| 11 | negative regulation of phagocytosis (GO:0050765) | 3.94444438 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.90836975 |
| 13 | detection of other organism (GO:0098543) | 3.87043843 |
| 14 | regulation of B cell differentiation (GO:0045577) | 3.81629657 |
| 15 | detection of bacterium (GO:0016045) | 3.80237231 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 3.76910789 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 3.73727364 |
| 18 | granulocyte activation (GO:0036230) | 3.69368327 |
| 19 | positive regulation of mast cell activation (GO:0033005) | 3.69345743 |
| 20 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.68951230 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.67203643 |
| 22 | megakaryocyte development (GO:0035855) | 3.65059858 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 3.56188997 |
| 24 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.53885461 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.53348030 |
| 26 | leukocyte aggregation (GO:0070486) | 3.50601118 |
| 27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.50248578 |
| 28 | mast cell activation (GO:0045576) | 3.49031358 |
| 29 | regulation of mast cell activation (GO:0033003) | 3.44518838 |
| 30 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.43213597 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 3.43204242 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41890487 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40634486 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 3.40634486 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40634486 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40634486 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40634486 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.40634486 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.37554724 |
| 40 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.37441981 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.33974872 |
| 42 | myeloid dendritic cell activation (GO:0001773) | 3.26077841 |
| 43 | positive regulation of mast cell degranulation (GO:0043306) | 3.25959517 |
| 44 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.25959517 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.24908548 |
| 46 | response to host immune response (GO:0052572) | 3.24908548 |
| 47 | regulation of erythrocyte differentiation (GO:0045646) | 3.23360547 |
| 48 | detection of external biotic stimulus (GO:0098581) | 3.20425793 |
| 49 | T cell homeostasis (GO:0043029) | 3.17498560 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.17155521 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.17155521 |
| 52 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.15612005 |
| 53 | viral transcription (GO:0019083) | 3.14528579 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14170883 |
| 55 | respiratory burst (GO:0045730) | 3.10428822 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07987954 |
| 57 | defense response to protozoan (GO:0042832) | 3.07979095 |
| 58 | definitive hemopoiesis (GO:0060216) | 3.07934630 |
| 59 | B cell mediated immunity (GO:0019724) | 3.07676445 |
| 60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.07089784 |
| 61 | response to peptidoglycan (GO:0032494) | 3.04545843 |
| 62 | regulation of antigen processing and presentation (GO:0002577) | 3.01115572 |
| 63 | response to protozoan (GO:0001562) | 2.99874168 |
| 64 | translational termination (GO:0006415) | 2.99243751 |
| 65 | microglial cell activation (GO:0001774) | 2.99201854 |
| 66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.98970253 |
| 67 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98741914 |
| 68 | response to interferon-beta (GO:0035456) | 2.96585902 |
| 69 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95874808 |
| 70 | macrophage activation (GO:0042116) | 2.93350652 |
| 71 | response to host (GO:0075136) | 2.92709134 |
| 72 | response to host defenses (GO:0052200) | 2.92709134 |
| 73 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92709134 |
| 74 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92519143 |
| 75 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89965486 |
| 76 | positive regulation of interferon-alpha production (GO:0032727) | 2.89848762 |
| 77 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.89834186 |
| 78 | positive regulation of granulocyte differentiation (GO:0030854) | 2.89725161 |
| 79 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.86132229 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 2.85802371 |
| 81 | T cell migration (GO:0072678) | 2.85665548 |
| 82 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.84471728 |
| 83 | detection of molecule of bacterial origin (GO:0032490) | 2.83902637 |
| 84 | mast cell degranulation (GO:0043303) | 2.83626838 |
| 85 | mast cell activation involved in immune response (GO:0002279) | 2.83626838 |
| 86 | detection of biotic stimulus (GO:0009595) | 2.83138866 |
| 87 | cellular extravasation (GO:0045123) | 2.81828545 |
| 88 | cellular response to interferon-beta (GO:0035458) | 2.79948040 |
| 89 | positive thymic T cell selection (GO:0045059) | 2.79599734 |
| 90 | lymphocyte homeostasis (GO:0002260) | 2.78658707 |
| 91 | myeloid dendritic cell differentiation (GO:0043011) | 2.78624365 |
| 92 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.78228182 |
| 93 | embryonic hemopoiesis (GO:0035162) | 2.78212771 |
| 94 | regulation of T cell tolerance induction (GO:0002664) | 2.77074589 |
| 95 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.75819792 |
| 96 | pinocytosis (GO:0006907) | 2.75775980 |
| 97 | response to type I interferon (GO:0034340) | 2.75695915 |
| 98 | response to muramyl dipeptide (GO:0032495) | 2.75576878 |
| 99 | regulation of platelet aggregation (GO:0090330) | 2.75490250 |
| 100 | regulation of interferon-alpha production (GO:0032647) | 2.74833582 |
| 101 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.74688997 |
| 102 | tolerance induction (GO:0002507) | 2.74156939 |
| 103 | negative regulation of innate immune response (GO:0045824) | 2.73913771 |
| 104 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.73836186 |
| 105 | regulation of regulated secretory pathway (GO:1903305) | 2.73554149 |
| 106 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.72732173 |
| 107 | negative regulation of interleukin-12 production (GO:0032695) | 2.72335333 |
| 108 | myeloid leukocyte activation (GO:0002274) | 2.72201873 |
| 109 | cellular response to type I interferon (GO:0071357) | 2.71760724 |
| 110 | type I interferon signaling pathway (GO:0060337) | 2.71760724 |
| 111 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.71212936 |
| 112 | response to interleukin-15 (GO:0070672) | 2.71150468 |
| 113 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70979127 |
| 114 | mature B cell differentiation (GO:0002335) | 2.70660837 |
| 115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70332191 |
| 116 | mature B cell differentiation involved in immune response (GO:0002313) | 2.69568027 |
| 117 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.68855240 |
| 118 | negative thymic T cell selection (GO:0045060) | 2.68532340 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.68119873 |
| 120 | DNA strand elongation (GO:0022616) | 2.67788804 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.66192966 |
| 122 | translational elongation (GO:0006414) | 2.66127374 |
| 123 | germinal center formation (GO:0002467) | 2.65538998 |
| 124 | negative T cell selection (GO:0043383) | 2.65480211 |
| 125 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.64367794 |
| 126 | granulocyte differentiation (GO:0030851) | 2.63234410 |
| 127 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.62331277 |
| 128 | interferon-gamma production (GO:0032609) | 2.61955533 |
| 129 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.61216138 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 2.58595302 |
| 131 | dendritic cell differentiation (GO:0097028) | 2.58553099 |
| 132 | DNA deamination (GO:0045006) | 2.58509672 |
| 133 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.58420532 |
| 134 | leukocyte degranulation (GO:0043299) | 2.58079889 |
| 135 | negative regulation of granulocyte differentiation (GO:0030853) | 2.57214625 |
| 136 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.56632869 |
| 137 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.56445508 |
| 138 | neutrophil activation (GO:0042119) | 2.56305790 |
| 139 | actin nucleation (GO:0045010) | 2.56100351 |
| 140 | myeloid cell development (GO:0061515) | 2.55446940 |
| 141 | regulation of granulocyte differentiation (GO:0030852) | 2.55264668 |
| 142 | cellular response to zinc ion (GO:0071294) | 2.53217057 |
| 143 | leukocyte homeostasis (GO:0001776) | 2.53083302 |
| 144 | macrophage activation involved in immune response (GO:0002281) | 2.52821359 |
| 145 | cotranslational protein targeting to membrane (GO:0006613) | 2.50560042 |
| 146 | protein targeting to ER (GO:0045047) | 2.50213450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.69249629 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.85215859 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.59202654 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.39999871 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.30800792 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.22163195 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.12639162 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.85519628 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.81184456 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.80242466 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.77018065 |
| 12 | * MYC_22102868_ChIP-Seq_BL_Human | 2.71076585 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61379385 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.56451627 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56129244 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.53320888 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46673524 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.31647006 |
| 19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30231722 |
| 20 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30174574 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27535038 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.23098598 |
| 23 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21253646 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17757597 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15632331 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08309824 |
| 27 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.08076489 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.03782241 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99819991 |
| 30 | * MAF_26560356_Chip-Seq_TH1_Human | 1.97913959 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97706659 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.96504019 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.95908871 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95857086 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95828611 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93501759 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90213424 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.89638420 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88797388 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85341148 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.82928043 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77833960 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76842990 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75710727 |
| 45 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.75077324 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71657158 |
| 47 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.70497858 |
| 48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.64454008 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64437246 |
| 50 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.63943324 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.63167758 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62525121 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62191479 |
| 54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.59810799 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58550770 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.58120516 |
| 57 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.57617138 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57253709 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.57122514 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.57043869 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53534105 |
| 62 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50897467 |
| 63 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50810766 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50333117 |
| 65 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49831887 |
| 66 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.42953795 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.40769108 |
| 68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40267902 |
| 69 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38152531 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35805032 |
| 71 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33666397 |
| 72 | * MAF_26560356_Chip-Seq_TH2_Human | 1.33198071 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32099784 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31733844 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30676653 |
| 76 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.30401233 |
| 77 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.28531033 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27155661 |
| 79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26578152 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25818403 |
| 81 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.24604735 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20846382 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19309955 |
| 84 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.19288086 |
| 85 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.18525803 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18007795 |
| 87 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.17810417 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17280800 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16385658 |
| 90 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16220616 |
| 91 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.15711993 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15208462 |
| 93 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.14794707 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12957215 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12316672 |
| 96 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.11246749 |
| 97 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10563504 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10129131 |
| 99 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.09948637 |
| 100 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09149187 |
| 101 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08313663 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05906756 |
| 103 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.04956488 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04361172 |
| 105 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02970866 |
| 106 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02762808 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02662160 |
| 108 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01772759 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00175219 |
| 110 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99690088 |
| 111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99004001 |
| 112 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98050903 |
| 113 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.97634350 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97292839 |
| 115 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96968846 |
| 116 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.96315770 |
| 117 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95538999 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95161395 |
| 119 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95028005 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94535349 |
| 121 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.93573309 |
| 122 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.92760815 |
| 123 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92396343 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90492612 |
| 125 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90165567 |
| 126 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89976938 |
| 127 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.89711697 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89645026 |
| 129 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89420849 |
| 130 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89417841 |
| 131 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88042375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.00332733 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.33357639 |
| 3 | MP0005671_abnormal_response_to | 3.11380878 |
| 4 | MP0000685_abnormal_immune_system | 2.94612276 |
| 5 | MP0003436_decreased_susceptibility_to | 2.92180884 |
| 6 | MP0001800_abnormal_humoral_immune | 2.82767217 |
| 7 | MP0009785_altered_susceptibility_to | 2.76389046 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.68795236 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.63965798 |
| 10 | * MP0005464_abnormal_platelet_physiology | 2.60967384 |
| 11 | MP0005387_immune_system_phenotype | 2.60802596 |
| 12 | MP0001790_abnormal_immune_system | 2.60802596 |
| 13 | MP0005025_abnormal_response_to | 2.57522593 |
| 14 | MP0002419_abnormal_innate_immunity | 2.55137653 |
| 15 | MP0002398_abnormal_bone_marrow | 2.53227385 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.52759579 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.52606515 |
| 18 | MP0002723_abnormal_immune_serum | 2.52575940 |
| 19 | MP0001819_abnormal_immune_cell | 2.50045565 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.38793588 |
| 21 | MP0003303_peritoneal_inflammation | 2.36514555 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.34053560 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 2.34053560 |
| 24 | MP0004808_abnormal_hematopoietic_stem | 2.24126206 |
| 25 | MP0000689_abnormal_spleen_morphology | 2.22054195 |
| 26 | MP0000716_abnormal_immune_system | 2.19162445 |
| 27 | MP0002722_abnormal_immune_system | 2.13011425 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.12146849 |
| 29 | MP0006082_CNS_inflammation | 2.10661243 |
| 30 | MP0002405_respiratory_system_inflammati | 2.07101844 |
| 31 | MP0003724_increased_susceptibility_to | 2.02803767 |
| 32 | MP0002166_altered_tumor_susceptibility | 2.01484004 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.99772993 |
| 34 | * MP0002429_abnormal_blood_cell | 1.96719486 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.88273506 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.83987829 |
| 37 | MP0001853_heart_inflammation | 1.82776697 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.81907527 |
| 39 | MP0000490_abnormal_crypts_of | 1.81277758 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.75953932 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.69597987 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.68771615 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.68713153 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.63289519 |
| 45 | MP0001873_stomach_inflammation | 1.62687177 |
| 46 | MP0002006_tumorigenesis | 1.60382212 |
| 47 | MP0005451_abnormal_body_composition | 1.58978900 |
| 48 | MP0009278_abnormal_bone_marrow | 1.56441744 |
| 49 | MP0004947_skin_inflammation | 1.53456147 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.53235686 |
| 51 | MP0003693_abnormal_embryo_hatching | 1.49881287 |
| 52 | MP0003866_abnormal_defecation | 1.49568025 |
| 53 | * MP0000465_gastrointestinal_hemorrhage | 1.49208432 |
| 54 | MP0008004_abnormal_stomach_pH | 1.46698071 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.41336752 |
| 56 | MP0008469_abnormal_protein_level | 1.40499674 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.38360164 |
| 58 | MP0000604_amyloidosis | 1.35741412 |
| 59 | MP0002132_abnormal_respiratory_system | 1.32730791 |
| 60 | MP0004510_myositis | 1.31853858 |
| 61 | MP0008260_abnormal_autophagy | 1.31321655 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.30809271 |
| 63 | MP0003077_abnormal_cell_cycle | 1.28907498 |
| 64 | MP0005310_abnormal_salivary_gland | 1.27736451 |
| 65 | MP0004147_increased_porphyrin_level | 1.27717919 |
| 66 | MP0003111_abnormal_nucleus_morphology | 1.27672495 |
| 67 | MP0008057_abnormal_DNA_replication | 1.24476846 |
| 68 | MP0002095_abnormal_skin_pigmentation | 1.22285032 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.21103728 |
| 70 | MP0000858_altered_metastatic_potential | 1.20851410 |
| 71 | MP0010307_abnormal_tumor_latency | 1.19085484 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.18584776 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.14267025 |
| 74 | MP0000343_altered_response_to | 1.12583459 |
| 75 | MP0002933_joint_inflammation | 1.10930850 |
| 76 | MP0008007_abnormal_cellular_replicative | 1.10852741 |
| 77 | MP0006054_spinal_hemorrhage | 1.09650369 |
| 78 | MP0009840_abnormal_foam_cell | 1.05602307 |
| 79 | MP0008058_abnormal_DNA_repair | 1.02442111 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.01383610 |
| 81 | MP0003448_altered_tumor_morphology | 0.94208831 |
| 82 | MP0009764_decreased_sensitivity_to | 0.92135529 |
| 83 | MP0003690_abnormal_glial_cell | 0.91782218 |
| 84 | MP0000313_abnormal_cell_death | 0.89195153 |
| 85 | MP0004883_abnormal_blood_vessel | 0.88382268 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 0.88148240 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.87663232 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 0.86231096 |
| 89 | MP0001851_eye_inflammation | 0.85827703 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.83546001 |
| 91 | MP0009763_increased_sensitivity_to | 0.82500171 |
| 92 | MP0003075_altered_response_to | 0.81372430 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.80801190 |
| 94 | MP0005164_abnormal_response_to | 0.76869787 |
| 95 | MP0008874_decreased_physiological_sensi | 0.75045733 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.72198836 |
| 97 | MP0001663_abnormal_digestive_system | 0.71662756 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 0.71409322 |
| 99 | MP0000371_diluted_coat_color | 0.66357409 |
| 100 | MP0003828_pulmonary_edema | 0.65613047 |
| 101 | MP0002998_abnormal_bone_remodeling | 0.65486623 |
| 102 | MP0005166_decreased_susceptibility_to | 0.65419308 |
| 103 | MP0008873_increased_physiological_sensi | 0.63266362 |
| 104 | MP0000598_abnormal_liver_morphology | 0.63094669 |
| 105 | MP0000249_abnormal_blood_vessel | 0.59465895 |
| 106 | MP0005165_increased_susceptibility_to | 0.58907040 |
| 107 | MP0003186_abnormal_redox_activity | 0.57992882 |
| 108 | MP0004381_abnormal_hair_follicle | 0.56175142 |
| 109 | MP0005381_digestive/alimentary_phenotyp | 0.56082530 |
| 110 | MP0000609_abnormal_liver_physiology | 0.54933160 |
| 111 | MP0001986_abnormal_taste_sensitivity | 0.54107794 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.54094263 |
| 113 | MP0000350_abnormal_cell_proliferation | 0.54063306 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.53501354 |
| 115 | MP0003329_amyloid_beta_deposits | 0.53208897 |
| 116 | MP0000920_abnormal_myelination | 0.53114933 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.52540632 |
| 118 | MP0002877_abnormal_melanocyte_morpholog | 0.52044138 |
| 119 | MP0003091_abnormal_cell_migration | 0.51912027 |
| 120 | MP0005023_abnormal_wound_healing | 0.51164142 |
| 121 | MP0005390_skeleton_phenotype | 0.50824895 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.50249172 |
| 123 | * MP0003795_abnormal_bone_structure | 0.49991048 |
| 124 | MP0005535_abnormal_body_temperature | 0.48053407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.25715691 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.61199698 |
| 3 | Chronic otitis media (HP:0000389) | 4.34672270 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.33349020 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.33349020 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.33349020 |
| 7 | IgM deficiency (HP:0002850) | 4.32493803 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.27454753 |
| 9 | Prolonged bleeding time (HP:0003010) | 4.22284482 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.14176083 |
| 11 | * Petechiae (HP:0000967) | 4.02849408 |
| 12 | Recurrent viral infections (HP:0004429) | 4.01671136 |
| 13 | Thrombocytosis (HP:0001894) | 4.00505271 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.78698989 |
| 15 | Myositis (HP:0100614) | 3.78590343 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 3.61205044 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.51118891 |
| 18 | Cellulitis (HP:0100658) | 3.47133562 |
| 19 | Meningitis (HP:0001287) | 3.34262872 |
| 20 | Recurrent skin infections (HP:0001581) | 3.33352038 |
| 21 | Recurrent bronchitis (HP:0002837) | 3.26538230 |
| 22 | Abnormal number of erythroid precursors (HP:0012131) | 3.21165646 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.19612935 |
| 24 | Impaired platelet aggregation (HP:0003540) | 3.19392418 |
| 25 | Abnormal platelet function (HP:0011869) | 3.19392418 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.17242096 |
| 27 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.14503394 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 3.11696843 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11262438 |
| 30 | * Epistaxis (HP:0000421) | 3.09267907 |
| 31 | Agammaglobulinemia (HP:0004432) | 3.09091454 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.04686169 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.04686169 |
| 34 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.03311466 |
| 35 | Increased mean platelet volume (HP:0011877) | 3.02174928 |
| 36 | Inflammation of the large intestine (HP:0002037) | 3.01951421 |
| 37 | Obstructive lung disease (HP:0006536) | 3.01543834 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01543834 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 3.00604546 |
| 40 | Abnormality of T cells (HP:0002843) | 2.99421799 |
| 41 | Pustule (HP:0200039) | 2.93426253 |
| 42 | Increased serum ferritin (HP:0003281) | 2.93324244 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 2.89791066 |
| 44 | Loss of speech (HP:0002371) | 2.87254512 |
| 45 | Nasal polyposis (HP:0100582) | 2.86225154 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.80888034 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.78890310 |
| 48 | Vasculitis (HP:0002633) | 2.73950212 |
| 49 | Aplastic anemia (HP:0001915) | 2.72231288 |
| 50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.70924204 |
| 51 | Increased cerebral lipofuscin (HP:0011813) | 2.69957271 |
| 52 | Purpura (HP:0000979) | 2.69335757 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.69053039 |
| 54 | Lymphopenia (HP:0001888) | 2.68766998 |
| 55 | Increased IgM level (HP:0003496) | 2.67376429 |
| 56 | Abnormality of the nasal mucosa (HP:0000433) | 2.65638020 |
| 57 | Colitis (HP:0002583) | 2.63518928 |
| 58 | Agnosia (HP:0010524) | 2.63200364 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.62499642 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.61601121 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.61272694 |
| 62 | Reticulocytopenia (HP:0001896) | 2.60187543 |
| 63 | T lymphocytopenia (HP:0005403) | 2.59223529 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.56530227 |
| 65 | Abnormality of the prostate (HP:0008775) | 2.56097276 |
| 66 | Gingival bleeding (HP:0000225) | 2.54792904 |
| 67 | Orchitis (HP:0100796) | 2.52304011 |
| 68 | B lymphocytopenia (HP:0010976) | 2.50334946 |
| 69 | Abnormality of B cell number (HP:0010975) | 2.50334946 |
| 70 | Disinhibition (HP:0000734) | 2.49731363 |
| 71 | Periodontitis (HP:0000704) | 2.49277913 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.48990556 |
| 73 | Gastrointestinal stroma tumor (HP:0100723) | 2.47711467 |
| 74 | Abnormal platelet volume (HP:0011876) | 2.45888841 |
| 75 | Hemoptysis (HP:0002105) | 2.44600586 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.42772622 |
| 77 | Encephalitis (HP:0002383) | 2.40667096 |
| 78 | Lymphoma (HP:0002665) | 2.40542375 |
| 79 | Granulocytopenia (HP:0001913) | 2.39229335 |
| 80 | Osteomyelitis (HP:0002754) | 2.37671985 |
| 81 | Stomatitis (HP:0010280) | 2.37418023 |
| 82 | Hypertensive crisis (HP:0100735) | 2.36572805 |
| 83 | IgG deficiency (HP:0004315) | 2.36308062 |
| 84 | Thyroiditis (HP:0100646) | 2.33323709 |
| 85 | Retrobulbar optic neuritis (HP:0100654) | 2.31231958 |
| 86 | Optic neuritis (HP:0100653) | 2.31231958 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 2.28232505 |
| 88 | Episodic fever (HP:0001954) | 2.27470577 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.26219347 |
| 90 | Dysostosis multiplex (HP:0000943) | 2.25263033 |
| 91 | Eosinophilia (HP:0001880) | 2.24977375 |
| 92 | Pallor (HP:0000980) | 2.24807094 |
| 93 | Keratoconjunctivitis (HP:0001096) | 2.20010895 |
| 94 | Severe combined immunodeficiency (HP:0004430) | 2.19991017 |
| 95 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.18859215 |
| 96 | Hypergammaglobulinemia (HP:0010702) | 2.17872930 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17477568 |
| 98 | Abnormality of eosinophils (HP:0001879) | 2.16291152 |
| 99 | Combined immunodeficiency (HP:0005387) | 2.15107077 |
| 100 | Amyloidosis (HP:0011034) | 2.14724786 |
| 101 | Gingivitis (HP:0000230) | 2.13076155 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12908072 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12908072 |
| 104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12908072 |
| 105 | Urticaria (HP:0001025) | 2.11518441 |
| 106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10445376 |
| 107 | * Leukocytosis (HP:0001974) | 2.10369122 |
| 108 | Pulmonary embolism (HP:0002204) | 2.09736460 |
| 109 | Myelodysplasia (HP:0002863) | 2.08545970 |
| 110 | Increased IgE level (HP:0003212) | 2.07021719 |
| 111 | Papilloma (HP:0012740) | 2.05981607 |
| 112 | Verrucae (HP:0200043) | 2.05981607 |
| 113 | Hematochezia (HP:0002573) | 2.05567971 |
| 114 | Pulmonary infiltrates (HP:0002113) | 2.04256134 |
| 115 | Arterial thrombosis (HP:0004420) | 2.04245962 |
| 116 | Chest pain (HP:0100749) | 2.03868711 |
| 117 | Thoracic kyphosis (HP:0002942) | 2.03531792 |
| 118 | Mutism (HP:0002300) | 2.02931447 |
| 119 | Amaurosis fugax (HP:0100576) | 2.02194778 |
| 120 | Poikiloderma (HP:0001029) | 2.02050946 |
| 121 | Polycythemia (HP:0001901) | 2.00103428 |
| 122 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99845980 |
| 123 | Mucopolysacchariduria (HP:0008155) | 1.99845980 |
| 124 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.99483913 |
| 125 | Albinism (HP:0001022) | 1.98807771 |
| 126 | Abnormality of the fingertips (HP:0001211) | 1.97486434 |
| 127 | Neutropenia (HP:0001875) | 1.96875936 |
| 128 | Polyneuropathy (HP:0001271) | 1.96863334 |
| 129 | Chronic sinusitis (HP:0011109) | 1.96604265 |
| 130 | Recurrent pneumonia (HP:0006532) | 1.95947742 |
| 131 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95429236 |
| 132 | Menorrhagia (HP:0000132) | 1.94539804 |
| 133 | Sepsis (HP:0100806) | 1.92493032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.61341660 |
| 2 | KIT | 2.87929522 |
| 3 | BLK | 2.75327707 |
| 4 | PRPF4B | 2.53286929 |
| 5 | TXK | 2.46385971 |
| 6 | EEF2K | 2.35471942 |
| 7 | BTK | 2.34754884 |
| 8 | ZAP70 | 2.30739396 |
| 9 | TYK2 | 2.23440867 |
| 10 | IRAK4 | 2.18792785 |
| 11 | JAK3 | 2.17170088 |
| 12 | TBK1 | 2.11253455 |
| 13 | STK10 | 2.07371359 |
| 14 | TEC | 2.02260264 |
| 15 | CSF1R | 2.00732743 |
| 16 | NME2 | 1.91391727 |
| 17 | SYK | 1.89634567 |
| 18 | TGFBR2 | 1.83242869 |
| 19 | MAP2K3 | 1.80999041 |
| 20 | TAOK3 | 1.78786874 |
| 21 | MAP3K14 | 1.76766979 |
| 22 | FGR | 1.76566525 |
| 23 | IKBKE | 1.74552852 |
| 24 | TAOK2 | 1.64927290 |
| 25 | CLK1 | 1.58785211 |
| 26 | TAOK1 | 1.56635942 |
| 27 | IKBKB | 1.52249004 |
| 28 | MAP3K3 | 1.51709458 |
| 29 | GRK6 | 1.48043759 |
| 30 | PIM2 | 1.47656490 |
| 31 | PKN2 | 1.47651346 |
| 32 | FLT3 | 1.43878944 |
| 33 | RIPK4 | 1.43766269 |
| 34 | ERN1 | 1.39499102 |
| 35 | FES | 1.35918209 |
| 36 | MAP3K10 | 1.35606142 |
| 37 | LCK | 1.34794478 |
| 38 | LYN | 1.29172529 |
| 39 | ITK | 1.27605936 |
| 40 | LRRK2 | 1.27382893 |
| 41 | PIM1 | 1.23439973 |
| 42 | HCK | 1.23298829 |
| 43 | IRAK3 | 1.18897857 |
| 44 | MAP3K1 | 1.15458379 |
| 45 | TGFBR1 | 1.11273488 |
| 46 | STK16 | 1.10608886 |
| 47 | BMPR2 | 1.10390595 |
| 48 | SIK3 | 1.10135678 |
| 49 | SCYL2 | 1.09642467 |
| 50 | MATK | 1.08153100 |
| 51 | CDC7 | 1.07948448 |
| 52 | NEK2 | 1.06511691 |
| 53 | JAK1 | 1.04612115 |
| 54 | RPS6KA4 | 1.00378328 |
| 55 | GRK7 | 0.98324359 |
| 56 | TRIB3 | 0.98137620 |
| 57 | EIF2AK1 | 0.97290533 |
| 58 | STK4 | 0.94404001 |
| 59 | WEE1 | 0.93367129 |
| 60 | KDR | 0.91235855 |
| 61 | CSK | 0.90263299 |
| 62 | ACVR1B | 0.88888409 |
| 63 | CDC42BPA | 0.85086536 |
| 64 | BMX | 0.84819666 |
| 65 | RPS6KB2 | 0.83441781 |
| 66 | VRK1 | 0.81666466 |
| 67 | JAK2 | 0.80630198 |
| 68 | CDK4 | 0.76376270 |
| 69 | CCNB1 | 0.75793818 |
| 70 | MAPK12 | 0.74622954 |
| 71 | SIK2 | 0.70827264 |
| 72 | CHUK | 0.70522936 |
| 73 | MAP3K6 | 0.70460767 |
| 74 | TESK2 | 0.68659862 |
| 75 | CAMKK2 | 0.68108611 |
| 76 | TNK2 | 0.67424887 |
| 77 | ATR | 0.66459314 |
| 78 | PRKCQ | 0.66195116 |
| 79 | BUB1 | 0.65503158 |
| 80 | MAP3K13 | 0.64293532 |
| 81 | RPS6KA6 | 0.63169333 |
| 82 | IRAK1 | 0.62596180 |
| 83 | NEK9 | 0.62404019 |
| 84 | PDPK1 | 0.61497316 |
| 85 | MAP3K11 | 0.61479811 |
| 86 | MAP3K5 | 0.60674453 |
| 87 | PASK | 0.59321795 |
| 88 | MAPK4 | 0.57959755 |
| 89 | MARK2 | 0.56145503 |
| 90 | BRSK2 | 0.55333157 |
| 91 | MARK3 | 0.54744029 |
| 92 | PAK4 | 0.54563455 |
| 93 | MAP3K8 | 0.54431907 |
| 94 | RPS6KC1 | 0.52518986 |
| 95 | RPS6KL1 | 0.52518986 |
| 96 | MAP3K12 | 0.52426728 |
| 97 | IRAK2 | 0.52066446 |
| 98 | KSR2 | 0.50432516 |
| 99 | TSSK6 | 0.49786311 |
| 100 | FYN | 0.49722716 |
| 101 | SMG1 | 0.49234120 |
| 102 | CDK6 | 0.49180715 |
| 103 | EPHB1 | 0.48922072 |
| 104 | MKNK1 | 0.48393491 |
| 105 | TRPM7 | 0.48327935 |
| 106 | DYRK3 | 0.48025042 |
| 107 | MAPK7 | 0.47767400 |
| 108 | MAPK11 | 0.47667651 |
| 109 | CDK19 | 0.45777097 |
| 110 | ARAF | 0.44828671 |
| 111 | MAPKAPK5 | 0.44757734 |
| 112 | NLK | 0.44355482 |
| 113 | FGFR4 | 0.44160447 |
| 114 | MAPKAPK2 | 0.43441183 |
| 115 | DDR2 | 0.42867804 |
| 116 | CDK7 | 0.42589469 |
| 117 | MST4 | 0.40420208 |
| 118 | PRKD2 | 0.40417752 |
| 119 | FGFR3 | 0.40045467 |
| 120 | MOS | 0.39486362 |
| 121 | EIF2AK3 | 0.39139265 |
| 122 | YES1 | 0.38805191 |
| 123 | MAP2K6 | 0.38476220 |
| 124 | BCKDK | 0.37886915 |
| 125 | PTK2B | 0.35378075 |
| 126 | PDK1 | 0.35266458 |
| 127 | TLK1 | 0.34630859 |
| 128 | HIPK2 | 0.34611038 |
| 129 | PIK3CG | 0.33932078 |
| 130 | CAMKK1 | 0.33644659 |
| 131 | RAF1 | 0.33307594 |
| 132 | AURKB | 0.32402789 |
| 133 | ABL1 | 0.31574611 |
| 134 | DAPK2 | 0.29799366 |
| 135 | RPS6KA2 | 0.29386879 |
| 136 | PRKCD | 0.29260084 |
| 137 | ABL2 | 0.28436735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.15550674 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.13887694 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63650481 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.35226911 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.33398391 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.21499602 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12903492 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.09841556 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.09404796 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07233333 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.07115019 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00532524 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99432637 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96174191 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95966292 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89770298 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.81802806 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.78429163 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74699223 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65281269 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.65280493 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64691819 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.60116970 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57163278 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.55615816 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.49625946 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47531685 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.42320040 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40881783 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38267244 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37007560 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.35620938 |
| 33 | Spliceosome_Homo sapiens_hsa03040 | 1.34163479 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33612457 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.29472225 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.28571011 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28356248 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.26647743 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.25912849 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24163864 |
| 41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.23772581 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23604741 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.21511761 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17988322 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.17064206 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.15266043 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.13917643 |
| 48 | * Platelet activation_Homo sapiens_hsa04611 | 1.11439500 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07571243 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03580041 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02064142 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.00661204 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00284705 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00075598 |
| 55 | Cell cycle_Homo sapiens_hsa04110 | 0.98566190 |
| 56 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.98322639 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97948984 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94754457 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94224069 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92647206 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91323109 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.91288093 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91066688 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86255387 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86093310 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85038692 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84742034 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83722534 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81226122 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80668650 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.80346295 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78218089 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77407065 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.76916345 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76356438 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75848674 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.73034929 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70252082 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68695701 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68512306 |
| 81 | RNA transport_Homo sapiens_hsa03013 | 0.66384203 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63529505 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.62728659 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.62531320 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61611247 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61573354 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60926721 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.60100746 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57873939 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.57107478 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56999093 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56869278 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56025571 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55823604 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.54040956 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52783183 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.52550847 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48391574 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45692624 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45456935 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44724816 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.44497141 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42314297 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41839845 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41129623 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40563345 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38646654 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37857627 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37756283 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37050887 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.36715133 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36240910 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34549960 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34098880 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33573130 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32860970 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29345403 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25047472 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23851169 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23086322 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22878561 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22866289 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22845206 |
| 124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20600143 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19877905 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.18886344 |

